ChatGPTã«ãã£ããã£ç»åãã¢ããããŒãããã ãã§ããã§ã€ã¯ãã¥ãŒã¹ã®ççžã倿ããä»¶
ã10äžäººã«16人ãããã®æ°åãåã°ã©ãã§èŠãããããšããªãã ãå®å¿ããŠããŸããŸããããå æ¥ãXã§åå®®é žããã¯ã¯ãã³ã«ã€ããŠã®æçš¿ãèŠãããæããšããããã£ãŠèšäºãæžããŸãããå®ã¯ãã®ãšããæçš¿ã®ãã£ããã£ç»åããã®ãŸãŸChatGPTã«ã¢ããããŒãããŠã¿ãã®ã§ãããããšè¿ã£ãŠããã®ã¯ãåãªãå 容ã®èŠçŽã§ã¯ãããŸããã§ãããæããããªãã»ã©ããšããªã£ãŠããŸãã»ã©éããããã€ãã®è«ççãªããæ¿ããææããŠãããã®ã§ããå ¬èªå¿çåž«ãšããŠä»äºãããŠãããšããããããæèã®ã¯ããã¯SNSã®ãã¡ãã¡ã«æœãã§ãããšæããŸãã仿¥ã¯ãChatGPTãæããŠãããå 容ã«ãç§ãªãã®è§£èª¬ãå ããŠã玹ä»ããããšæããŸãã
â å°ããèŠããæ°åã«ã¯ãã¯ãããã
ãŸãäžã€ç®ã«ææãããã®ã¯ãã10äžäººã«16人ããšããæ°åã®èŠãæ¹ã«ã€ããŠã§ããã
ä»®ã«ãããã1幎éã«10äžäººäž16人ãçºçããããšããæå³ã ãšãããšã16÷100,000ã§0.016%ã«ãªããŸããåã°ã©ããå°æ°ç¹1æ¡ã§è¡šç€ºããã°ããããã«ã0.0%ããšããèŠããŸãããã§ãããããã¯ãªã¹ã¯ããŒãã«ãªã£ãããã§ã¯ãªããåã«äžžããçµæãæ°åãèŠããªããªã£ãŠããã ããªã®ã§ãã
ç§ã¯ãããèŠããšããã1幎éã«äº€éäºæ ã§æ»äº¡ãã確çã¯éåžžã«å°ãããããåã°ã©ãã«ããã°ã»ãŒ100%ãç¡äºãã ããã·ãŒããã«ãã¯å¿ èŠãªãããšèšã£ãŠããã®ãšãæ§é ãšããŠã¯ãŸã£ããåãã ãšæããŸãããæ¥µç«¯ã«æãããããããŸããããè«çãšããŠã¯åãããšãããŠããã®ã§ãã
ããã«èŠèœãšãããã¡ãªã®ããã10äžäººã«16人ããšããã®ã¯éåžžã1幎éãããã®çœ¹æ£çã ãšããç¹ã§ããããããäžçã®ãã¡ã«ããã確çãã ãšé¯èŠããŠããŸããšããªã¹ã¯ã¯å®éãããã£ãšå°ããèŠããŠããŸããŸããåœç«ããç ç©¶ã»ã³ã¿ãŒã®2023幎ã®ããŒã¿ã§ã¯ãæ¥æ¬äººå¥³æ§ãçæ¶¯ã®ãã¡ã«åå®®é žãããšèšºæããã確çã¯çŽ1.3%ãããã79人ã«1人ãšãããŠããŸããã幎é0.016%ããšãçæ¶¯ã§79人ã«1人ãã§ã¯ãåãåãå°è±¡ããŸã£ããéã£ãŠããŸãããã
å¿çåŠã®äžçã«ã¯ãæ°åã®èŠãæ¹ã²ãšã€ã§å€æãå€ãã£ãŠããŸãããã¬ãŒãã³ã°å¹æããšããçŸè±¡ããããŸããä»åã®ã±ãŒã¹ã¯ããŸãã«ãã®ãã¬ãŒãã³ã°ã®åã䜿ã£ãŠããªã¹ã¯ãå®éããå°ããæããããŠããå žåäŸã ãšèšããã§ãããã
⡠話ããéãã«ããæ¿ãã£ãŠããç¬é
äºã€ç®ã«æ°ã¥ããããã®ã¯ãè°è«ã®éäžã§è«ç¹ããã£ãšããæ¿ãã£ãŠããç®æãããã€ããã£ãããšã§ãã
ãŸãããç æ°ãçããã®ã ãããã¯ã¯ãã³ãæã€å¿ èŠã¯ãªãããšãã䞻匵ãããã¯äžèŠãã£ãšããããèãããŸãããäºé²ãå¿ èŠãã©ããã¯çºççã ãã§æ±ºãŸããã®ã§ã¯ãããŸãããçºççãç æ°ã®éããäºé²å¹æãå¯åå¿ãè²»çšãè² æ ããããããã¹ãŠå€©ç§€ã«ãããŠãã¯ãããŠãæã€äŸ¡å€ããããã©ããããèŠããŠããŸããçç¬ç ãç Žå·é¢šã®ããã«ãçºçé »åºŠã¯äœããŠãäºé²ãã䟡å€ãé«ãç æ°ã¯ä»ã«ããããããããŸãããã
åçåŽåçã«ãããšã9䟡ã¯ã¯ãã³ã¯åå®®é žããã®åå ãšãªãHPVã®åã®ãã¡ã80ã90%ãã«ããŒãããšãããŠããŸããã¹ãŠã§ãŒãã³ã§çŽ167äžäººã察象ã«è¡ãããç ç©¶ã§ããè¥ãå¹Žéœ¢ã§æ¥çš®ãã女æ§ãã¡ã®æµžæœ€æ§åå®®é žããã倧ããæžå°ããŠããããšãå ±åãããŠããŸããè°è«ãã¹ããªã®ã¯ã0.016%ããçºçããªãããšããæ°åã§ã¯ãªãããæ¥çš®ã«ãã£ãŠå°æ¥ã®ãããã©ãã ãæžãããã®å©çãšå¯åå¿ãã©ãæ¯ã¹ããããªã®ã ãšæããŸãã
ããã²ãšã€æ°ã«ãªã£ãã®ãããææãç œã£ãŠãããããã¯ã¯ãã³æšé²ã®äž»åŒµã¯ééã£ãŠããããšããè«æ³ã§ãã説æã®ä»æ¹ãäžå®ãããããããŠããããšãšãã¯ã¯ãã³ã«å¹æããªãããšã¯ããŸã£ããå¥ã®è©±ã§ããããã®å»åž«ã¯æã話ã°ãããããã ãããå«ç ã¯èºããã®ãªã¹ã¯ãé«ããããšãã説æãééãã ããšã¯ãªããªãã®ãšåãã§ããããè©±ãæ¹ãåæ©ãžã®æ¹å€ãšã䞻匵ãã®ãã®ã®çåœã¯ãåããŠèããå¿ èŠããããŸãã
ãããŠããã³ããã¯ã¯ãã³ã®ç¶æ³ãšå šãåãã ããšããäŸããCOVID-19ã¯ã¯ãã³ãšHPVã¯ã¯ãã³ã§ã¯ãç åäœãææçµè·¯ããçºçãŸã§ã®æéãã察象幎霢ããèšåºè©Šéšã®ããæ¹ãéããŸãããé£è¡æ©äºæ ããã£ããããèªåè»ãåãããã«å±éºã ããšèšã£ãŠãããããªãã®ã§ãå ±éç¹ããã¯ã¯ãã³ã§ãããããšã ãã§ã¯ãçµè«ãéããããšã¯ã§ããŸããã
ããã«ããæ²³é倧è£ãæŠèŠå€§è£ãšåãããšããææããã補è¬äŒç€Ÿã®æå ã®ããã«èŠããããšãã衚çŸãå¿çåŠã§ã¯ãçºèšã®äžèº«ã§ã¯ãªãçºèšè ã®å±æ§ã§æ£ããã倿ããŠããŸãããšããé£åº§ã®èª€è¬¬(genetic fallacy)ããšåŒã³ãŸããæ¿æ²»å®¶ã®å§¿å¢ã«åé¡ããã£ããšããŠãããã®æ¿æ²»å®¶ãæ¯æãããã®ãèªåçã«ééãã«ãªãããã§ã¯ãããŸãããå©ççžåããããã©ããã確èªããããšã¯å€§åã§ããããå©ççžåããããããããªãâç ç©¶ãééã£ãŠããâã¯ã¯ãã³ã«å¹æããªãããšããé£èºã¯ãè«çãšããŠã¯æç«ããŠããªãã®ã§ããWHOããHPVææãåããç å€ãåå®®é žãããã®ãã®ãäºé²ã§ãããšããããŒã¿ãããšã«ãæ¥çš®ãæšå¥šããŠããŸããèŠãã¹ããªã®ã¯çºèšè ã§ã¯ãªããããŒã¿ãªã®ã ãšããããããŠæããŸããã
â¢ãæšé²æŽŸãã®åŽã«ãããã§ã¢ããæ±ããããå Žé¢
ãããŸã§èªããšãããããã¯ã¯ãã³æšé²åŽã®èšãåã¯å
šéšæ£ããã®ãããšæããããããããŸãããã§ãããChatGPTã®ææã¯ãããã§ãè峿·±ããã®ã§ããã
ç»åã®äžã«ãã£ããå šå¡ãæ¥çš®ããŸããã!ããšãã匷ãåŒã³ãããããã¯ãæšé²æŽŸãå®éã«ãã䞻匵ããŠãããšãããããåå¯ŸæŽŸã®æçš¿ã®äžã§ãæšé²æŽŸã¯ãããªæ¥µç«¯ãªããšãèšã£ãŠããããšãã圢ã§ç€ºãããŠãã衚çŸã§ãããçžæã®äž»åŒµããå®éãããæå®çã§æ¥µç«¯ãªåœ¢ã«çœ®ãæããŠããå©ããããã¯ãèäººåœ¢è«æ³(ã¹ãããŒãã³)ããšåŒã°ãããããããè«æ³ã®ã²ãšã€ã§ããèªã¿æã®ææ ãç œãã«ã¯å¹æçãããããŸãããããã§ã¢ãªè°è«ãšã¯èšããŸããã
ãã®ããã§ããããããŠå»åŠçã«äžå¯§ãªäŒãæ¹ãèãããªãããå šå¡ãæ¥çš®ããŸããã!ããšæå®ããããããã察象幎霢ã§ã¯æ¥çš®ã«ããå©çãäžå©çãäžåããšè©äŸ¡ãããŠãããæ¥çš®ãæšå¥šãããŠããŸãã广ãšå¯åå¿ãçè§£ããããã§å€æããŠãã ããããšãã説æã®ã»ãããèª å®ã ãšèšããŸããåçåŽåçèªèº«ããæ¥çš®ã¯åŒ·å¶ã§ã¯ãªãã广ãšãªã¹ã¯ãçè§£ããããã§å€æãããã®ã ãšæèšããŠããŸãã
ãŸããç·æ§ãžã®HPVã¯ã¯ãã³ã®èª¬æãšããŠãåå®®é žããã®åã°ã©ãã ããèŠããã®ã¯äžååã ãšããææãããªãã»ã©ãšæããŸãããç·æ§ã«ãšã£ãŠã¯ãèéãããé°èãããäžåœé ãããå°åã³ã³ãžããŒãã®äºé²ãšãããå¥ã®å©çããããŸããHPVã¯ã女æ§ã ãã®ææçã§ã¯ãªãã®ã§ãã
æ°åã®è£åŽã«ãããæèã®ã¯ã»ã
ãããŸã§ã®å
容ããå
¬èªå¿çåž«ãšããç«å Žããå°ãæŽçãããŠãã ããã
ä»åã®æçš¿ã§ããè¿ãããŠããã®ã¯ãã確çãå°ããèŠããããšããšãäºé²ãã䟡å€ãå°ããããšãããåããã®ãšããŠæ±ã£ãŠããŸãæ··åã§ãããæ°åãäžžããŠããŸãã°ããªã¹ã¯ã¯ç°¡åã«èŠããªããªããŸããããã©ãç æ°ã¯äžçãéããŠèµ·ãããããã®ã§ããä»ã®æ¥æ¬ã®çµ±èšã§ã¯ãåå®®é žããã®ç涯ãªã¹ã¯ã¯ããã79人ã«1人ããã®æ°åã¯ãåã°ã©ãã®äžã«ã¯çŸããŠããŸããã
ãããŠã¯ã¯ãã³ãè©äŸ¡ãããšãã¯ããç æ°ã«ãªã人ãäœ%ããã ãã§ãªãããã¯ã¯ãã³ã«ãã£ãŠäœäººãæããã®ãããå¯åå¿ã¯ã©ã®çšåºŠãªã®ããããåããã®ããã§æ¯ã¹ãå¿ èŠããããŸããåæã«ããå°éå®¶ãèšã£ãŠããããæ£ããããããæ¿æ²»å®¶ã補è¬äŒç€Ÿãé¢ãã£ãŠããããééã£ãŠãããããã©ã¡ããç§åŠçãªèãæ¹ãšã¯èšããŸãããç§ãã¡ãèŠãã¹ããªã®ã¯ããã€ã ã£ãŠäººç©ã§ã¯ãªãããŒã¿ãªã®ã ãšæããŸãã
ãŸãšã
仿¥ãäŒããããã£ãããšãããããããŠäžã€ã«ãŸãšããŸãã
äžã€ç®ã¯ãå°ããèŠããæ°åã«ã¯ã¯ãããããšããããšã§ããåã°ã©ãã§0.0%ã«èŠããŠããããã¯äžžããçµæã§ãã£ãŠããªã¹ã¯ããŒããšããæå³ã§ã¯ãããŸããã幎éã®çºççãšãäžçã®ãã¡ã«ããã確çã¯ããŸã£ããå¥ã®è©±ã§ãã
äºã€ç®ã¯ã話ã¯éãã«ããæ¿ãã£ãŠãããšããããšã§ããçºççã®äœãã説æã®ä»æ¹ãžã®æ¹å€ãä»ã®ã¯ã¯ãã³ãšã®å®æãªæ¯èŒãçºèšè ãžã®æ»æãããããè«æ³ã¯ãã©ãããã¯ã¯ãã³ã«å¹æããããã©ããããšããæ¬é¡ããã¯ãå°ããã€ãããŠããŸãã
äžã€ç®ã¯ããã§ã¢ãªç®ç·ãæã¡ç¶ãããšããããšã§ããæ¹å€ããåŽã ãã§ãªããæšé²ããåŽã®äŒãæ¹ã«ããæ¹åã§ããéšåã¯ãã£ãšãããŸããã©ã¡ããäžæ¹ã"æµ"ã«ããŠããŸããšãèŠããªããªããã®ãããã®ã ãšæããŸãã
SNSã§æµããŠããæ å ±ã«ãå¿ãæºãã¶ãããããšã¯èª°ã«ã§ããããŸããããã§ããäžåºŠç«ã¡æ¢ãŸã£ãŠããã®æ°åã¯ãäœãšæ¯ã¹ãŠãããã ãããããã®è©±ã¯ãéäžã§ããæ¿ãã£ãŠããªãã ãããããšèããŠã¿ãããã®å°ããªç¿æ £ããããªãèªèº«ãããããŠããªãã®å€§åãªäººãå®ãåã«ãªããŸããããªãã«ã¯ããã®åãã¡ãããšåãã£ãŠããŸãã
é·æã«ãããããããæåŸãŸã§ãä»ãåããã ããããããšãããããŸããããããããããæå³ã§"ã¡ãã£ãšã ãããã¢ãã¯ãª"æ å ±ãå±ããŠãããããšæããŸãã
åè
ã»åœç«ããç ç©¶ã»ã³ã¿ãŒãææ°ããçµ±èšã ã»åçåŽåçãHPVã¯ã¯ãã³ã«é¢ããQ&Aã ã»World Health OrganizationãHPV vaccinationã ã»The New England Journal of MedicineãHPV Vaccination and the Risk of Invasive Cervical Cancerã
#ãã§ã€ã¯ãã¥ãŒã¹ #ãã¡ã¯ããã§ã㯠#HPVã¯ã¯ãã³ #ã¡ãã£ã¢ãªãã©ã·ãŒ #èªç¥ãã€ã¢ã¹
ãããªãšæã£ããå¿æŽãããïŒ
ãããããã°å¿æŽãé¡ãããŸããããã ãããããã¯ãå·çã®ããã®æžç±è³Œå
¥ããAIã®ããã«äœ¿ãããŠããã ããŸãã